Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-May-23 6:53 PM View:  | Wu Mijia Director | NovaBay Pharmaceuticals, Inc. (NBY) | 11-May-23 | Option Exercise | 858 | -- | -- | 100% 0.86K to 1.72K | |
| 15-May-23 6:53 PM View: | Sit Swan Director | NovaBay Pharmaceuticals, Inc. (NBY) | 11-May-23 | Option Exercise | 858 | -- | -- | 100% 0.86K to 1.72K | |
| 15-May-23 6:54 PM View: | Freiman Paul E. Director | NovaBay Pharmaceuticals, Inc. (NBY) | 11-May-23 | Option Exercise | 858 | -- | -- | 93% 0.93K to 1.78K | |
| 15-May-23 6:52 PM View: | Zheng Yongxiang Director | NovaBay Pharmaceuticals, Inc. (NBY) | 11-May-23 | Option Exercise | 858 | -- | -- | 100% 0 to 0.86K | |
| 15-May-23 6:54 PM View: | Zheng Yenyou Director | NovaBay Pharmaceuticals, Inc. (NBY) | 11-May-23 | Option Exercise | 858 | -- | -- | 100% 0.86K to 1.72K | |
| 15-May-23 6:53 PM View: | Garlikov Julie Director | NovaBay Pharmaceuticals, Inc. (NBY) | 11-May-23 | Option Exercise | 858 | -- | -- | 100% 0 to 0.86K | |
| 07-Dec-22 4:55 PM View: | Kunin Jeffrey President, DERMAdoctor, LLC | NovaBay Pharmaceuticals, Inc. (NBY) | 06-Dec-22 | Private Sale | 1 | $1.81 | $1.81 | (100%) 1 to 0 | |
| 07-Dec-22 4:55 PM View: | Kunin Audrey Chief Product Officer | NovaBay Pharmaceuticals, Inc. (NBY) | 06-Dec-22 | Private Sale Duplicate | 1 | $1.81 | $1.81 | (100%) 1 to 0 | |
| 23-Nov-22 4:16 PM View: | Kunin Audrey Chief Product Officer | NovaBay Pharmaceuticals, Inc. (NBY) | 21-Nov-22 | Private Sale Duplicate | 5,960 | $2.10 | $12,545.20 | (100%) 5.96K to 0 | |
| 23-Nov-22 4:15 PM View: | Kunin Jeffrey President, DERMAdoctor, LLC | NovaBay Pharmaceuticals, Inc. (NBY) | 21-Nov-22 | Private Sale | 5,960 | $2.10 | $12,545.20 | (100%) 5.96K to 0 | |
| 16-Sep-22 8:45 PM View: | Hall Justin CEO, GC and Director Director | NovaBay Pharmaceuticals, Inc. (NBY) | 14-Sep-22 | Private Purchase | 10,000 | $0.15 | $1,500.00 | 14% 73.17K to 83.17K | |
| 16-Sep-22 6:24 PM View: | Kunin Audrey Chief Product Officer Director | NovaBay Pharmaceuticals, Inc. (NBY) | 14-Sep-22 | Sale | 291,368 | $0.16 | $46,094.40 | (58%) 500.0K to 208.63K | |
| 16-Sep-22 6:26 PM View: | Kunin Jeffrey President, DERMAdoctor, LLC | NovaBay Pharmaceuticals, Inc. (NBY) | 14-Sep-22 | Sale Duplicate | 291,368 | $0.16 | $46,094.40 | (58%) 500.0K to 208.63K | |
| 24-May-22 7:31 PM View: | Zheng Yenyou Director | NovaBay Pharmaceuticals, Inc. (NBY) | 21-May-22 | Option Exercise | 30,000 | -- | -- | 100% 0 to 30.0K | |
| 24-May-22 7:33 PM View: | Wu Mijia Director | NovaBay Pharmaceuticals, Inc. (NBY) | 21-May-22 | Option Exercise | 30,000 | -- | -- | 100% 0 to 30.0K | |
| 24-May-22 7:30 PM View: | Freiman Paul E. Director | NovaBay Pharmaceuticals, Inc. (NBY) | 21-May-22 | Option Exercise | 30,000 | -- | -- | 1298% 2.31K to 32.31K | |
| 24-May-22 7:28 PM View: | Sit Swan Director | NovaBay Pharmaceuticals, Inc. (NBY) | 21-May-22 | Option Exercise | 30,000 | -- | -- | 100% 0 to 30.0K | |
| 06-Dec-21 4:30 PM View: | Jones Andrew D. CFO | NovaBay Pharmaceuticals, Inc. (NBY) | 06-Dec-21 | Market Purchase | 36,765 | $0.44 | $16,176.60 | 41% 90.7K to 127.46K | 0% |
| 06-Dec-21 8:03 PM View: | Hall Justin CEO, GC and Director Director | NovaBay Pharmaceuticals, Inc. (NBY) | 06-Dec-21 | Market Purchase | 69,767 | $0.43 | $29,999.80 | 2049% 3.4K to 73.17K | 0% |
| 07-Dec-21 5:43 PM View: | Kunin Audrey Chief Product Officer | NovaBay Pharmaceuticals, Inc. (NBY) | 03-Dec-21 | Market Purchase | 101,650 | $0.46 | $47,013.10 | 26% 398.35K to 500.0K | (8%) |
| 07-Dec-21 5:46 PM View: | Kunin Jeffrey President, DERMAdoctor, LLC | NovaBay Pharmaceuticals, Inc. (NBY) | 03-Dec-21 | Market Purchase Duplicate | 101,650 | $0.46 | $47,013.10 | 26% 398.35K to 500.0K | (8%) |
| 06-Dec-21 4:30 PM View: | Jones Andrew D. CFO | NovaBay Pharmaceuticals, Inc. (NBY) | 03-Dec-21 | Market Purchase | 8,690 | $0.44 | $3,823.60 | 11% 82.01K to 90.7K | 0% |
| 06-Dec-21 4:31 PM View: | Kunin Audrey Chief Product Officer | NovaBay Pharmaceuticals, Inc. (NBY) | 02-Dec-21 | Market Purchase | 262,369 | $0.48 | $124,888.00 | 193% 135.98K to 398.35K | (10%) |
| 06-Dec-21 4:31 PM View: | Kunin Jeffrey President, DERMAdoctor, LLC | NovaBay Pharmaceuticals, Inc. (NBY) | 02-Dec-21 | Market Purchase Duplicate | 262,369 | $0.48 | $124,888.00 | 193% 135.98K to 398.35K | (10%) |
| 03-Dec-21 4:30 PM View: | Kunin Audrey Chief Product Officer | NovaBay Pharmaceuticals, Inc. (NBY) | 01-Dec-21 | Market Purchase Duplicate | 14,848 | $0.49 | $7,275.52 | 12% 121.13K to 135.98K | (5%) |
| 03-Dec-21 4:30 PM View: | Kunin Jeffrey President, DERMAdoctor, LLC | NovaBay Pharmaceuticals, Inc. (NBY) | 01-Dec-21 | Market Purchase | 14,848 | $0.49 | $7,275.52 | 12% 121.13K to 135.98K | (5%) |
| 02-Dec-21 4:30 PM View: | Kunin Audrey Chief Product Officer | NovaBay Pharmaceuticals, Inc. (NBY) | 30-Nov-21 | Market Purchase | 30,000 | $0.46 | $13,800.00 | 33% 91.13K to 121.13K | 14% |
| 02-Dec-21 4:30 PM View: | Kunin Jeffrey President, DERMAdoctor, LLC | NovaBay Pharmaceuticals, Inc. (NBY) | 30-Nov-21 | Market Purchase Duplicate | 30,000 | $0.46 | $13,800.00 | 33% 91.13K to 121.13K | 14% |
| 24-Nov-21 4:46 PM View: | Kunin Audrey Chief Product Officer | NovaBay Pharmaceuticals, Inc. (NBY) | 23-Nov-21 | Market Purchase Duplicate | 66,133 | $0.46 | $30,368.30 | 265% 25.0K to 91.13K | (2%) |
| 24-Nov-21 4:46 PM View: | Kunin Jeffrey President, DERMAdoctor, LLC | NovaBay Pharmaceuticals, Inc. (NBY) | 23-Nov-21 | Market Purchase | 66,133 | $0.46 | $30,368.30 | 265% 25.0K to 91.13K | (2%) |
| 24-Nov-21 4:46 PM View: | Kunin Audrey Chief Product Officer | NovaBay Pharmaceuticals, Inc. (NBY) | 22-Nov-21 | Market Purchase Duplicate | 25,000 | $0.46 | $11,500.00 | 100% 0 to 25.0K | < 1% |
| 24-Nov-21 4:46 PM View: | Kunin Jeffrey President, DERMAdoctor, LLC | NovaBay Pharmaceuticals, Inc. (NBY) | 22-Nov-21 | Market Purchase | 25,000 | $0.46 | $11,500.00 | 100% 0 to 25.0K | < 1% |
| 07-May-21 6:00 PM View: | Jones Andrew D. CFO | NovaBay Pharmaceuticals, Inc. (NBY) | 04-May-21 | Payment of Exercise | 77,994 | $0.79 | $61,833.60 | (49%) 160.0K to 82.01K | 7% |
| 19-Aug-20 4:24 PM View: | Wu Mijia Director | NovaBay Pharmaceuticals, Inc. (NBY) | 17-Aug-20 | Private Sale | 20,000 | $1.35 | $27,000.00 | (100%) 20.0K to 0 | |
| 19-Aug-20 4:24 PM View: | Wu Mijia Director | NovaBay Pharmaceuticals, Inc. (NBY) | 17-Aug-20 | Grant | 20,000 | $0.30 | $6,000.00 | 100% 0 to 20.0K | |
| 04-Aug-20 6:04 PM View: | Fu Jian Ping 10% Owner | NovaBay Pharmaceuticals, Inc. (NBY) | 01-Aug-20 | Market Sale | 1,302,350 | $1.23 | $1,601,890.00 | (25%) 5.3M to 4.0M | 41% |
| 06-Aug-19 8:18 AM View: | Sieczkarek Mark M | NovaBay Pharmaceuticals, Inc. (NBY) | 30-Jul-19 | Grant | 167,938 | -- | -- | 17% 988.94K to 1.16M | |
| 13-Jun-19 9:32 PM View: | Pioneer Pharma (hong Kong) ... 10% Owner | NovaBay Pharmaceuticals, Inc. (NBY) | 11-Jun-19 | Market Sale | 24,326 | $4.04 | $98,277.00 | (< 1%) 5.21M to 5.19M | 83% |
| 13-Jun-19 9:46 PM View: | Fu Jian Ping 10% Owner | NovaBay Pharmaceuticals, Inc. (NBY) | 11-Jun-19 | Market Sale | 380,954 | $3.84 | $1,462,860.00 | (7%) 5.68M to 5.3M | 82% |
| 13-Jun-19 6:03 AM View: | Wu Mijia Director | NovaBay Pharmaceuticals, Inc. (NBY) | 11-Jun-19 | Market Sale | 15,873 | $4.04 | $64,126.90 | (100%) 15.87K to 0 | 83% |
| 13-Jun-19 6:03 AM View: | Wu Mijia Director | NovaBay Pharmaceuticals, Inc. (NBY) | 10-Jun-19 | Market Sale | 47,619 | $2.03 | $96,666.60 | (75%) 63.49K to 15.87K | 65% |
| 11-Oct-16 6:44 PM View: | Fu Jian Ping 10% Owner | NovaBay Pharmaceuticals, Inc. (NBY) | 11-Oct-16 | Exercise (in-the money or at-the-money) | 126,985 | $3.15 | $400,003.00 | 3% 3.86M to 3.98M | |
| 03-Oct-16 4:32 PM View: | Sieczkarek Mark M CEO Director | NovaBay Pharmaceuticals, Inc. (NBY) | 30-Sep-16 | Exercise (in-the money or at-the-money) | 273,447 | $1.91 | $522,284.00 | 38% 715.5K to 988.95K | |
| 03-Oct-16 4:24 PM View: | Wu Mijia Director | NovaBay Pharmaceuticals, Inc. (NBY) | 30-Sep-16 | Exercise (in-the money or at-the-money) | 15,873 | $3.15 | $50,000.00 | 50% 31.75K to 47.62K | |
| 26-Sep-16 5:45 PM View: | Pioneer Pharma (singapore) ... 10% Owner | NovaBay Pharmaceuticals, Inc. (NBY) | 22-Sep-16 | Exercise (in-the money or at-the-money) | 181,300 | $1.81 | $328,153.00 | 5% 3.7M to 3.88M | |
| 26-Sep-16 6:14 PM View: | Fu Jian Ping 10% Owner | NovaBay Pharmaceuticals, Inc. (NBY) | 22-Sep-16 | Exercise (in-the money or at-the-money) | 968,587 | $1.91 | $1,850,000.00 | 34% 2.89M to 3.86M | |
| 26-Sep-16 6:05 PM View: | Pioneer Pharma (singapore) ... 10% Owner | NovaBay Pharmaceuticals, Inc. (NBY) | 22-Sep-16 | Exercise (in-the money or at-the-money) | 1,308,900 | $1.91 | $2,500,000.00 | 34% 3.88M to 5.19M | |
| 02-Aug-16 1:26 PM View: | Pioneer Pharma (singapore) ... 10% Owner | NovaBay Pharmaceuticals, Inc. (NBY) | 01-Aug-16 | Grant | 1,308,900 | $1.91 | $2,500,000.00 | 55% 2.39M to 3.7M | |
| 02-Aug-16 1:18 PM View: | Sieczkarek Mark M CEO Director | NovaBay Pharmaceuticals, Inc. (NBY) | 01-Aug-16 | Grant | 261,780 | $1.91 | $500,000.00 | 58% 453.72K to 715.5K | |
| 16-May-16 2:03 PM View: | Fu Jian Ping 10% Owner | NovaBay Pharmaceuticals, Inc. (NBY) | 09-May-16 | Grant | 1,937,170 | $1.91 | $3,700,000.00 | 204% 950.56K to 2.89M |
